U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2013
589
Name Type Language
COAGULATION FACTOR X
Preferred Name English
COAGULATION FACTOR X HUMAN
Common Name English
FACTOR X
Common Name English
HUMAN FACTOR X
Common Name English
Coagadex component Coagulation Factor X (Human)
Brand Name English
HUMAN COAGULATION FACTOR X
Common Name English
COAGULATION FACTOR X, HUMAN
Common Name English
Classification Tree Code System Code
WHO-ATC B02BD13
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
FDA ORPHAN DRUG 225806
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
FDA ORPHAN DRUG 305310
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
NCI_THESAURUS C78311
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
LOINC 49639-8
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
NDF-RT N0000184169
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
LOINC 3222-7
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
EU-Orphan Drug EU/3/07/471
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
LOINC 3223-5
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
FDA ORPHAN DRUG 246907
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
Code System Code Type Description
NDF-RT
N0000007914
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY Blood Coagulation Factors [Chemical/Ingredient]
RXCUI
4262
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
ALTERNATIVE RxNorm
NCI_THESAURUS
C82272
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
SMS_ID
100000130073
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
NDF-RT
N0000175979
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY Increased Coagulation Activity [PE]
DAILYMED
0P94UQE6SY
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
EVMPD
SUB13816MIG
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
FDA UNII
0P94UQE6SY
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
EVMPD
SUB41252
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
MESH
D005170
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
DRUG BANK
DB13148
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
RXCUI
1426166
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
LACTMED
Coagulation Factor X
Created by admin on Mon Mar 31 20:30:38 GMT 2025 , Edited by admin on Mon Mar 31 20:30:38 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966